Literature DB >> 24161372

Care strategy for death rattle in terminally ill cancer patients and their family members: recommendations from a cross-sectional nationwide survey of bereaved family members' perceptions.

Yoichi Shimizu1, Mitsunori Miyashita2, Tatsuya Morita3, Kazuki Sato2, Satoru Tsuneto4, Yasuo Shima5.   

Abstract

CONTEXT: Bereaved family members witnessing a patient's death rattle often experience distress. However, the benefits of specific care measures aimed at decreasing death rattle-associated family distress have not yet been evaluated.
OBJECTIVES: To clarify death rattle-related emotional distress levels among family members and their perceptions of the need for death rattle care improvement and explore the factors influencing both these issues.
METHODS: A cross-sectional questionnaire survey of bereaved family members of cancer patients was conducted in 95 palliative care units in June 2007.
RESULTS: Six hundred sixty-three questionnaires were mailed out, and 390 (61%) responses were analyzed. Among these, 181 (46%) respondents experienced death rattle. Of these, 66% reported high distress levels and 53% perceived a strong need for improved death rattle care. Factors influencing high distress levels were the gender (female) of family members, unawareness about death rattle being a natural phenomenon, and their fear and distressing interpretations of death rattle. Factors influencing perceptions of a strong need for improved care were the gender (male) of family members, severity of death rattle, death rattle-associated discomfort to patients, family members' experiences of inadequate nursing care (e.g., repositioning) and insufficient consultation about suctioning, and their perception of uncomfortable smells.
CONCLUSION: To decrease family-perceived distress, medical staff should alleviate patient symptoms and suffering with a comprehensive care strategy, try to decrease uncomfortable smells, and communicate with family members to address distressing interpretations and fears.
Copyright © 2014 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Death rattle; neoplasm; respiratory sounds; terminal care

Mesh:

Year:  2013        PMID: 24161372     DOI: 10.1016/j.jpainsymman.2013.07.010

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  6 in total

Review 1.  Updates in palliative care - recent advancements in the pharmacological management of symptoms.

Authors:  Angela Star; Jason W Boland
Journal:  Clin Med (Lond)       Date:  2018-02       Impact factor: 2.659

2.  Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life: The SILENCE Randomized Clinical Trial.

Authors:  Harriëtte J van Esch; Lia van Zuylen; Eric C T Geijteman; Esther Oomen-de Hoop; Bregje A A Huisman; Heike S Noordzij-Nooteboom; Renske Boogaard; Agnes van der Heide; Carin C D van der Rijt
Journal:  JAMA       Date:  2021-10-05       Impact factor: 56.272

3.  Scopolaminebutyl given prophylactically for death rattle: study protocol of a randomized double-blind placebo-controlled trial in a frail patient population (the SILENCE study).

Authors:  Harriëtte J van Esch; Lia van Zuylen; Esther Oomen-de Hoop; Agnes van der Heide; Carin C D van der Rijt
Journal:  BMC Palliat Care       Date:  2018-09-07       Impact factor: 3.234

Review 4.  Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer.

Authors:  Masanori Mori; Takashi Yamaguchi; Yoshinobu Matsuda; Kozue Suzuki; Hiroaki Watanabe; Ryo Matsunuma; Jun Kako; Kengo Imai; Yuko Usui; Yoshihisa Matsumoto; David Hui; David Currow; Tatsuya Morita
Journal:  ESMO Open       Date:  2020-09-30

5.  Prognostication of the Last Days of Life.

Authors:  Masanori Mori; Tatsuya Morita; Eduardo Bruera; David Hui
Journal:  Cancer Res Treat       Date:  2022-03-30       Impact factor: 5.036

6.  Understanding relatives' experience of death rattle.

Authors:  Harriëtte J van Esch; Martine E Lokker; Judith Rietjens; Lia van Zuylen; Carin C D van der Rijt; Agnes van der Heide
Journal:  BMC Psychol       Date:  2020-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.